314741-38-3 Usage
General Description
1,2,4-Piperazinetricarboxylic acid,4-(1,1-dimethylethyl)2-methyl1-(phenylmethyl)ester,(2S)- is a chemical compound with a complex molecular structure. It consists of piperazine, carboxylic acid, tert-butyl, methyl, and phenylmethyl groups. 1,2,4-Piperazinetricarboxylic acid,4-(1,1-dimethylethyl)2-methyl1-(phenylmethyl)ester,(2S)- is an ester derivative of piperazine and is classified as a chiral molecule with a stereo configuration of (2S)-. It is commonly used in organic synthesis and pharmaceutical research due to its potential biological activity and pharmacological properties. This chemical may have applications in medicinal chemistry and drug development, but its specific uses and effects would depend on further research and testing.
Check Digit Verification of cas no
The CAS Registry Mumber 314741-38-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,1,4,7,4 and 1 respectively; the second part has 2 digits, 3 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 314741-38:
(8*3)+(7*1)+(6*4)+(5*7)+(4*4)+(3*1)+(2*3)+(1*8)=123
123 % 10 = 3
So 314741-38-3 is a valid CAS Registry Number.
InChI:InChI=1/C19H26N2O6/c1-18(2,3)27-16(24)20-10-11-21(19(4,13-20)15(22)23)17(25)26-12-14-8-6-5-7-9-14/h5-9H,10-13H2,1-4H3,(H,22,23)/t19-/m0/s1
314741-38-3Relevant articles and documents
ANTIBIOTIC COMPOUNDS, PHARMACEUTICAL FORMULATIONS THEREOF AND METHODS AND USES THEREFOR
-
Page/Page column 327; 328, (2017/06/30)
The present invention relates to compounds of formula (I) wherein G1 to G8 are as defined herein. The compounds are PK inhibitors and as such represent a new approach to treating pathogenic infections, including multidrug resistant pathogens. Disclosed herein are the compounds of formula (I), pharmaceutical compositions comprising the compounds of formula (I) and their use in the treatment of antimicrobial infection. (Formula (1))
THROMBIN INHIBITORS
-
, (2013/10/21)
Compounds of the invention are useful in inhibiting thrombin and associated thrombotic occlusions having the following structure: (I) or a pharmaceutically acceptable salt thereof, wherein Q is CH2, NR4, O, S, S(O) or S(O2
QUINOLINE DERIVATIVES AS ANTIBACTERIALS
-
Page 12, (2010/02/06)
The present invention relates to a compound of formula (I) or a pharmaceutically acceptable salt and/or N-oxide thereof: corresponding novel medicaments, pharmaceutical compositions and/or methods of